R P Markus Selected Research

N-pentanoyl-2-benzyltryptamine (DH97)

1/2021

MT1 and MT2 melatonin receptors play opposite roles in brain cancer progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R P Markus Research Topics

Disease

3	Inflammation (Inflammations) 12/2007 - 01/2001
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Glioma (Gliomas) 01/2021
1	Medulloblastoma 01/2021
1	Neoplasms (Cancer) 01/2021
1	Wounds and Injuries (Trauma) 02/2009
1	Necrosis 02/2009
1	Snake Bites (Snake Bite) 01/2006

Drug/Important Bio-Agent (IBA)

4	MelatoninIBA 01/2021 - 01/2001
2	Hormones (Hormone)IBA 11/2001 - 01/2001
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2021
1	indolamineIBA 01/2021
1	N-pentanoyl-2-benzyltryptamine (DH97)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	CorticosteroneIBA 02/2009
1	GlucocorticoidsIBA 12/2007
1	VenomsIBA 01/2006
1	N-acetylserotoninIBA 11/2001